Skin cancer and new treatment perspectives: a review.

Skin cancers are by far the most common malignancy of humans, particularly in the white population. The growing incidence of cutaneous malignancies has heralded the need for multiple treatment options. Although surgical modalities remain the mainstay of treatment, new research and fresh innovation are still required to reduce morbidity and mortality. Approaches for skin cancer may pass through new technological methods instead of new molecules. The first part of this paper provides a review of the state of the art regarding skin cancer disease as well as epidemiology data. Then, it describes the gold standards of the current recommended therapies worldwide and the actual needs of these patients. This is the first paper that highlights the novel and future therapeutic perspectives for the treatment of skin malignancies, new therapeutic agents and promising technological approaches, from nanotechnology to immunotherapy.

[1]  N. Lowe An overview of ultraviolet radiation, sunscreens, and photo-induced dermatoses. , 2006, Dermatologic clinics.

[2]  Hua Yu,et al.  Gene gun application in the generation of effector T cells for adoptive immunotherapy , 2000, Cancer Immunology, Immunotherapy.

[3]  M. Willander,et al.  Photodynamic effects of zinc oxide nanowires in skin cancer and fibroblast , 2014, Lasers in Medical Science.

[4]  S. Franceschi,et al.  Cutaneous malignant melanoma: epidemiological considerations. , 1992, Seminars in surgical oncology.

[5]  S. Dowdy,et al.  Protein transduction technology. , 2002, Current opinion in biotechnology.

[6]  Katherine W Ferrara,et al.  Therapeutic effects of paclitaxel-containing ultrasound contrast agents. , 2006, Ultrasound in medicine & biology.

[7]  Naomi J Halas,et al.  Nanoshell-enabled photothermal cancer therapy: impending clinical impact. , 2008, Accounts of chemical research.

[8]  R. Heller,et al.  Delivery of Interleukin-15 to B16 Melanoma by Electroporation Leads to Tumor Regression and Long-term Survival , 2014, Technology in cancer research & treatment.

[9]  F. S. Ferreira,et al.  Biodegradable polymeric nanocapsules based on poly(DL-lactide) for genistein topical delivery: obtention, characterization and skin permeation studies. , 2013, Journal of biomedical nanotechnology.

[10]  S. Pazzaglia,et al.  Basal Cell Carcinoma and Its Development , 2004, Cancer Research.

[11]  Y. Kong,et al.  Opportunistic Autoimmune Disorders Potentiated by Immune-Checkpoint Inhibitors Anti-CTLA-4 and Anti-PD-1 , 2014, Front. Immunol..

[12]  C. Chiang,et al.  Gold nanoshells-mediated bimodal photodynamic and photothermal cancer treatment using ultra-low doses of near infra-red light. , 2014, Biomaterials.

[13]  D. Irvine,et al.  Enhancing radiotherapy by lipid nanocapsule-mediated delivery of amphiphilic gold nanoparticles to intracellular membranes. , 2014, ACS nano.

[14]  Erik C. Dreaden,et al.  Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. , 2008, Cancer letters.

[15]  A. Rook,et al.  Toll receptor agonist therapy of skin cancer and cutaneous T-cell lymphoma , 2014, Current opinion in oncology.

[16]  L. Kemény,et al.  [Electrochemotherapy of melanoma cutaneous metastases]. , 2010, Orvosi hetilap.

[17]  S. Fulda,et al.  Targeting of XIAP Combined with Systemic Mesenchymal Stem Cell‐Mediated Delivery of sTRAIL Ligand Inhibits Metastatic Growth of Pancreatic Carcinoma Cells , 2010, Stem cells.

[18]  H. Horton,et al.  IL-2 plasmid electroporation: from preclinical studies to phase I clinical trial. , 2008, Methods in molecular biology.

[19]  Hiroyuki Honda,et al.  Antitumor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma , 2003, Cancer Immunology, Immunotherapy.

[20]  N. Sethy,et al.  Cerium oxide nanoparticles prevent apoptosis in primary cortical culture by stabilizing mitochondrial membrane potential , 2014, Free radical research.

[21]  C. Mai,et al.  Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers , 2013, OncoTargets and therapy.

[22]  J. Mano,et al.  Pectin-coated chitosan microgels crosslinked on superhydrophobic surfaces for 5-fluorouracil encapsulation. , 2013, Carbohydrate polymers.

[23]  S. Jelveh,et al.  Gold Nanostructures as a Platform for Combinational Therapy in Future Cancer Therapeutics , 2011, Cancers.

[24]  D. Schadendorf,et al.  Improved survival with ipilimumab in patients with metastatic melanoma. , 2010, The New England journal of medicine.

[25]  N. Rosales,et al.  Encapsulation of the UV-DNA repair enzyme T4 endonuclease V in liposomes and delivery to human cells. , 1989, The Journal of investigative dermatology.

[26]  Jon J Briggs,et al.  Immunostimulatory Effects of CpG-ODN Upon Dendritic Cell-Based Immunotherapy in a Murine Melanoma Model , 2004, Journal of immunotherapy.

[27]  R. Parhi,et al.  Preparation and characterization of solid lipid nanoparticles-a review. , 2012, Current drug discovery technologies.

[28]  Eneida A. Mendonça,et al.  A Phase III Skin Cancer Chemoprevention Study of DFMO: Long-term Follow-up of Skin Cancer Events and Toxicity , 2012, Cancer Prevention Research.

[29]  Yifei Xing,et al.  The effect of high intensity focused ultrasound treatment on metastases in a murine melanoma model. , 2008, Biochemical and biophysical research communications.

[30]  J. Adán,et al.  In vivo anticancer evaluation of the hyperthermic efficacy of anti-human epidermal growth factor receptor-targeted PEG-based nanocarrier containing magnetic nanoparticles , 2014, International journal of nanomedicine.

[31]  Vinayak Sant,et al.  Graphene-based nanomaterials for drug delivery and tissue engineering. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[32]  Warren C W Chan,et al.  Nanoparticle-mediated cellular response is size-dependent. , 2008, Nature nanotechnology.

[33]  S. Calderwood Molecular Cochaperones: Tumor Growth and Cancer Treatment , 2013, Scientifica.

[34]  Stuart K. Calderwood,et al.  Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications , 2005, Cell stress & chaperones.

[35]  Adèle C. Green,et al.  Epidemiology of Malignant Melanoma , 2010 .

[36]  A. Seifalian,et al.  A new era of cancer treatment: carbon nanotubes as drug delivery tools , 2011, International journal of nanomedicine.

[37]  P. Russell,et al.  Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy? , 2010, Stem cells.

[38]  A. Chang,et al.  Use of gene gun for genetic immunotherapy : in vitro and in vivo methods. , 2001, Methods in molecular medicine.

[39]  Nathan Johnston,et al.  Non-covalently functionalized single-walled carbon nanotube for topical siRNA delivery into melanoma. , 2014, Biomaterials.

[40]  John A Thompson,et al.  Treatment of metastatic melanoma: an overview. , 2009, Oncology.

[41]  Hans Leuenberger,et al.  Albumin Nanospheres as Carriers for Passive Drug Targeting: An Optimized Manufacturing Technique , 2004, Pharmaceutical Research.

[42]  A. Stratigos,et al.  Antiangiogenic and antiapoptotic treatment in advanced melanoma. , 2013, Clinics in dermatology.

[43]  A. Vidimos,et al.  Nonsurgical treatment of nonmelanoma skin cancer. , 2011, Dermatologic clinics.

[44]  A. S. Sobolev,et al.  Study of efficiency of the modular nanotransporter for targeted delivery of photosensitizers to melanoma cell nuclei in vivo , 2012, Doklady Biochemistry and Biophysics.

[45]  M. Anwer,et al.  Optimization of 5-flurouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer , 2010, International journal of medical sciences.

[46]  M. Blagosklonny Selective anti-cancer agents as anti-aging drugs , 2013, Cancer biology & therapy.

[47]  F. Pontén,et al.  PATCHED and p53 gene alterations in sporadic and hereditary basal cell cancer , 2001, Oncogene.

[48]  Liping Tang,et al.  Enhanced intratumoral uptake of quantum dots concealed within hydrogel nanoparticles , 2008, Nanotechnology.

[49]  N. Hioka,et al.  An efficient rose bengal based nanoplatform for photodynamic therapy. , 2014, Chemistry.

[50]  M. Lacouture,et al.  Non-rash skin toxicities associated with novel targeted therapies. , 2006, Clinical lung cancer.

[51]  N. Yang,et al.  Gene gun delivery systems for cancer vaccine approaches. , 2009, Methods in molecular biology.

[52]  U. Liebert,et al.  Complex cancer gene therapy in mice melanoma , 2002, Langenbeck's Archives of Surgery.

[53]  D. Schadendorf,et al.  Lack of clinical efficacy of imatinib in metastatic melanoma , 2005, British Journal of Cancer.

[54]  J. Willmann,et al.  Ultrasound and Microbubble–Mediated Gene Delivery in Cancer: Progress and Perspectives , 2013, Investigative radiology.

[55]  Chang-Sik Ha,et al.  Synthesis and Drug‐Delivery Behavior of Chitosan‐Functionalized Graphene Oxide Hybrid Nanosheets , 2011 .

[56]  Deevya L. Narayanan,et al.  Review: Ultraviolet radiation and skin cancer , 2010, International journal of dermatology.

[57]  Soumen Das,et al.  Cerium oxide nanoparticles: applications and prospects in nanomedicine. , 2013, Nanomedicine.

[58]  F. Hodi,et al.  Molecular Pathways: Next-Generation Immunotherapy—Inhibiting Programmed Death-Ligand 1 and Programmed Death-1 , 2012, Clinical Cancer Research.

[59]  Blazej Zbytek,et al.  Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system. , 2012, Advances in anatomy, embryology, and cell biology.

[60]  E. Winer,et al.  Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer. , 2001, Journal of the National Cancer Institute. Monographs.

[61]  Rainer H Müller,et al.  Lipid nanoparticles for parenteral delivery of actives. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[62]  Zhuang Liu,et al.  Nano-graphene oxide for cellular imaging and drug delivery , 2008, Nano research.

[63]  C. Elmets,et al.  Prospects for skin cancer treatment and prevention: the potential contribution of an engineered virus. , 2011, The Journal of investigative dermatology.

[64]  A. S. Sobolev,et al.  Engineered modular recombinant transporters: application of new platform for targeted radiotherapeutic agents to alpha-particle emitting 211 At. , 2008, International journal of radiation oncology, biology, physics.

[65]  Carlos Roberto Antonio,et al.  Nanotechnology in Dermatology* , 2014, Anais brasileiros de dermatologia.

[66]  R. Saladi,et al.  The causes of skin cancer: a comprehensive review. , 2005, Drugs of today.

[67]  Cheri X Deng,et al.  Ultrasound-induced cell membrane porosity. , 2004, Ultrasound in medicine & biology.

[68]  A. S. Sobolev Modular nanotransporters of anticancer drugs conferring cell specificity and higher efficiency , 2009, Biochemistry (Moscow).

[69]  Laura Marcu,et al.  In vitro and in vivo evaluation and a case report of intense nanosecond pulsed electric field as a local therapy for human malignancies , 2007, International journal of cancer.

[70]  R. Orecchia,et al.  Radiotherapy-induced ear toxicity. , 2003, Cancer treatment reviews.

[71]  D. Morton,et al.  Surgery for distant melanoma metastasis. , 2012, Cancer journal.

[72]  C. Dispenza,et al.  Polymeric Nanogels: Nanocarriers For Drug Delivery Application , 2012 .

[73]  P. Ascierto,et al.  Interferon alpha for the adjuvant treatment of melanoma: review of international literature and practical recommendations from an expert panel on the use of interferon , 2014, Journal of chemotherapy.

[74]  Xiaohua Huang,et al.  Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. , 2006, Journal of the American Chemical Society.

[75]  J. Belanger Perillyl alcohol: applications in oncology. , 1998, Alternative medicine review : a journal of clinical therapeutic.

[76]  Brett M. Coldiron,et al.  Incidence estimate of nonmelanoma skin cancer in the United States, 2006. , 2010, Archives of dermatology.

[77]  C. Morton,et al.  Guidelines for the management of basal cell carcinoma , 2008, The British journal of dermatology.

[78]  J. West,et al.  Immunotargeted nanoshells for integrated cancer imaging and therapy. , 2005, Nano letters.

[79]  Yu-Ying He,et al.  Enhanced photodynamic efficacy towards melanoma cells by encapsulation of Pc4 in silica nanoparticles. , 2009, Toxicology and applied pharmacology.

[80]  Michael J Sailor,et al.  Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. , 2008, Angewandte Chemie.

[81]  A. Hauschild,et al.  Phase III randomized clinical trial comparing tremelimumab with standard-of-care chemotherapy in patients with advanced melanoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[82]  Sandra C. Mwakwari,et al.  Historic perspective on the use of AuNPs in medicine , 2008 .

[83]  F. Marincola,et al.  Electrochemotherapy for the management of melanoma skin metastasis: a review of the literature and possible combinations with immunotherapy , 2014, Archives of Dermatological Research.

[84]  A. Enk,et al.  Genetic immunization of mice with human tyrosinase‐related protein 2: Implications for the immunotherapy of melanoma , 2000, International journal of cancer.

[85]  Jyothi U. Menon,et al.  Nanomaterials for Photo-Based Diagnostic and Therapeutic Applications , 2013, Theranostics.

[86]  J. Dai,et al.  PEGylated graphene oxide-mediated protein delivery for cell function regulation. , 2012, ACS applied materials & interfaces.

[87]  J. Rivers The detection and management of dysplastic nevi and early melanoma , 1992, World Journal of Surgery.

[88]  J. Leonardi-Bee,et al.  A systematic review of worldwide incidence of nonmelanoma skin cancer , 2012, The British journal of dermatology.

[89]  Yu Shyr,et al.  Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. , 2012, The New England journal of medicine.

[90]  A. Sieroń,et al.  Photodynamic therapy in treatment of cutaneous and choroidal melanoma. , 2013, Photodiagnosis and photodynamic therapy.

[91]  B. Michniak-Kohn,et al.  Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases. , 2013, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[92]  Robert E. Nordquist,et al.  Clinical effects of in situ photoimmunotherapy on late-stage melanoma patients , 2010, Cancer biology & therapy.

[93]  D. Alberts,et al.  Chemoprevention of Human Actinic Keratoses by Topical dl-α-tocopherol , 2009, Cancer Prevention Research.

[94]  S. Mitragotri,et al.  Induction of cancer-specific cytotoxicity towards human prostate and skin cells using quercetin and ultrasound , 2005, British Journal of Cancer.

[95]  Y. Lim,et al.  Poly (γ-glutamic acid) based combination of water-insoluble paclitaxel and TLR7 agonist for chemo-immunotherapy. , 2014, Biomaterials.

[96]  A. Geller,et al.  Epidemiology of melanoma and nonmelanoma skin cancer. , 2003, Seminars in oncology nursing.

[97]  J. Kristl,et al.  The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. , 2010, International journal of pharmaceutics.

[98]  M. Guan,et al.  Icariside II potentiates paclitaxel-induced apoptosis in human melanoma A375 cells by inhibiting TLR4 signaling pathway. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[99]  R. Gutzmer,et al.  Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas , 2008, British Journal of Cancer.

[100]  John Ballato,et al.  Single-cell-level microplasma cancer therapy. , 2011, Small.

[101]  L. Zitvogel,et al.  The Critical Role of IL-15 in the Antitumor Effects Mediated by the Combination Therapy Imatinib and IL-21 , 2008, The Journal of Immunology.

[102]  Xin Li,et al.  The preparation and drug delivery of a graphene-carbon nanotube-Fe3O4 nanoparticle hybrid. , 2013, Journal of materials chemistry. B.

[103]  A. Nomizo,et al.  Effect of iontophoresis on topical delivery of doxorubicin-loaded solid lipid nanoparticles. , 2014, Journal of biomedical nanotechnology.

[104]  Reinhard Dummer,et al.  Skin cancer : a world-wide perspective , 2011 .

[105]  Hicham A. Chibli,et al.  Comparative cytotoxicity of gold–doxorubicin and InP–doxorubicin conjugates , 2012, Nanotechnology.

[106]  Sikandar G. Khan,et al.  Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study. , 2005, Carcinogenesis.

[107]  F. Rossetti,et al.  PLGA nanoparticles as delivery systems for protoporphyrin IX in topical PDT: cutaneous penetration of photosensitizer observed by fluorescence microscopy. , 2013, Journal of nanoscience and nanotechnology.

[108]  K. Tanabe,et al.  Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive review , 2014, The British journal of dermatology.

[109]  J. McCubrey,et al.  Molecular targeted therapy in melanoma: a way to reverse resistance to conventional drugs. , 2012, Current drug delivery.

[110]  K. Madison,et al.  Barrier function of the skin: "la raison d'être" of the epidermis. , 2003, The Journal of investigative dermatology.

[111]  K. Flaherty,et al.  Melanoma: new insights and new therapies. , 2012, The Journal of investigative dermatology.

[112]  C. Garland,et al.  Rising trends in melanoma. An hypothesis concerning sunscreen effectiveness. , 1993, Annals of epidemiology.

[113]  J. Eberle,et al.  BH3‐only proteins – possible proapoptotic triggers for melanoma therapy , 2014, Experimental dermatology.

[114]  N. Khlebtsov,et al.  Gold nanoparticles in biomedical applications: recent advances and perspectives. , 2012, Chemical Society reviews.

[115]  X. Liang,et al.  [The use of gene gun in cancer gene therapy]. , 2000, Zhonghua yi xue za zhi.

[116]  Wenyi Wei,et al.  Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer. , 2013, Journal of genetics and genomics = Yi chuan xue bao.

[117]  Guy Vallancien,et al.  High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. , 2003, Journal of endourology.

[118]  A. Eggermont,et al.  Advances in systemic treatment of melanoma. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[119]  R. Lopez,et al.  Development of nitrosyl ruthenium complex-loaded lipid carriers for topical administration: improvement in skin stability and in nitric oxide release by visible light irradiation. , 2010, Journal of pharmaceutical and biomedical analysis.

[120]  Soumen Das,et al.  Combination of Conventional Chemotherapeutics with Redox-Active Cerium Oxide Nanoparticles—A Novel Aspect in Cancer Therapy , 2014, Molecular Cancer Therapeutics.

[121]  A. Slominski,et al.  Neuroendocrinology of the skin. , 2000, Endocrine reviews.

[122]  A. Jindal,et al.  Nanocarriers and nanoparticles for skin care and dermatological treatments , 2013, Indian dermatology online journal.

[123]  E. Celis,et al.  A novel combinatorial cancer immunotherapy , 2014, Oncoimmunology.

[124]  A. Bosserhoff,et al.  Cold atmospheric plasma, a new strategy to induce senescence in melanoma cells , 2013, Experimental dermatology.

[125]  Zhijun Zhang,et al.  Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. , 2010, Small.

[126]  S. Karrer,et al.  Neue Entwicklungen in der photodynamischen Therapie , 2013, Der Hautarzt.

[127]  A. Tedesco,et al.  Quantitative approach to skin field cancerization using a nanoencapsulated photodynamic therapy agent: a pilot study , 2013, Clinical, cosmetic and investigational dermatology.

[128]  S. Nair,et al.  Development and evaluation of 5-fluorouracil loaded chitin nanogels for treatment of skin cancer. , 2013, Carbohydrate polymers.

[129]  P. Workman,et al.  Discovery of small molecule cancer drugs: Successes, challenges and opportunities , 2012, Molecular oncology.

[130]  K. K. Singh,et al.  Etoposide loaded solid lipid nanoparticles for curtailing B16F10 melanoma colonization in lung. , 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[131]  James T. Elder,et al.  Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin. , 2007, The American journal of pathology.

[132]  J H Senior,et al.  Fate and behavior of liposomes in vivo: a review of controlling factors. , 1987, Critical reviews in therapeutic drug carrier systems.

[133]  G. Weiner,et al.  CpG oligodeoxynucleotides as immunotherapy in cancer. , 2008, Update on cancer therapeutics.

[134]  Mark J. Smyth,et al.  The TRAIL apoptotic pathway in cancer onset, progression and therapy , 2008, Nature Reviews Cancer.

[135]  T. Wu,et al.  Enhancement of Tumor-Specific T Cell–Mediated Immunity in Dendritic Cell–Based Vaccines by Mycobacterium tuberculosis Heat Shock Protein X , 2014, The Journal of Immunology.

[136]  R. Velmurugan,et al.  Nanostructured Lipid Carriers: A potential drug carrier for cancer chemotherapy , 2012, Lipids in Health and Disease.

[137]  A P Cullen,et al.  The human health effects of ozone depletion and interactions with climate change , 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[138]  N. Hayward,et al.  Enhancement of DNA repair using topical T4 endonuclease V does not inhibit melanoma formation in Cdk4R24C/R24C/Tyr‐NrasQ61K mice following neonatal UVR , 2010, Pigment cell & melanoma research.

[139]  R. Asmatulu,et al.  Skin cancer treatment by albumin/5-Fu loaded magnetic nanocomposite spheres in a mouse model. , 2013, Journal of biotechnology.

[140]  Á. Villanueva,et al.  Metallo‐naphthalocyanines as photothermal sensitisers for experimental tumours: In Vitro and in vivo studies , 2009, Lasers in surgery and medicine.

[141]  K. Flaherty,et al.  Inhibition of mutated, activated BRAF in metastatic melanoma. , 2010, The New England journal of medicine.

[142]  Dapeng Liu,et al.  Synthesis of 3D Hierarchical Fe3O4/Graphene Composites with High Lithium Storage Capacity and for Controlled Drug Delivery , 2011 .

[143]  A. Akbarzadeh,et al.  Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine , 2012, Nanoscale Research Letters.

[144]  H. Gensler Prevention byα-difluoromethylornithine of skin carcinogenesis and immunosuppression induced by ultraviolet irradiation , 2005, Journal of Cancer Research and Clinical Oncology.

[145]  C. Vachon,et al.  Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. , 2007, Mayo Clinic proceedings.

[146]  K. Togsverd-Bo,et al.  [Organ transplant recipients need intensive control and treatment of skin cancer]. , 2013, Ugeskrift for laeger.

[147]  N. Smith Applications of ultrasonic skin permeation in transdermal drug delivery , 2008, Expert opinion on drug delivery.

[148]  S. Ugurel,et al.  Skin toxicity of anti‐cancer therapy , 2008, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[149]  A. Sarasin,et al.  The molecular pathways of ultraviolet-induced carcinogenesis. , 1999, Mutation research.

[150]  Hiroyuki Koide,et al.  The rational design of a synthetic polymer nanoparticle that neutralizes a toxic peptide in vivo , 2011, Proceedings of the National Academy of Sciences.

[151]  D. Miklavčič,et al.  Modulation of Activity of Known Cytotoxic Ruthenium(III) Compound (KP418) with Hampered Transmembrane Transport in Electrochemotherapy In Vitro and In Vivo , 2014, The Journal of Membrane Biology.

[152]  J. A. Bishop,et al.  British Association of Dermatologists Clinical Standards Unit. Revised U.K. guidelines for the management of cutaneous melanoma , 2010 .

[153]  E. Traversa,et al.  The effect of cerium valence states at cerium oxide nanoparticle surfaces on cell proliferation. , 2014, Biomaterials.

[154]  T. Liu,et al.  Epidemiology of malignant melanoma. , 1996, The Surgical clinics of North America.

[155]  Randy Gordon,et al.  Skin cancer: an overview of epidemiology and risk factors. , 2013, Seminars in oncology nursing.

[156]  Amarnath Sharma,et al.  Liposomes in drug delivery: Progress and limitations , 1997 .

[157]  Joseph Kost,et al.  Ultrasound and transdermal drug delivery. , 2004, Drug discovery today.

[158]  E. Rosenthal,et al.  Phase 1 study of erlotinib plus radiation therapy in patients with advanced cutaneous squamous cell carcinoma. , 2013, International journal of radiation oncology, biology, physics.

[159]  B. Armstrong,et al.  The epidemiology of UV induced skin cancer. , 2001, Journal of photochemistry and photobiology. B, Biology.

[160]  P. Workman,et al.  Exploiting the cancer genome: strategies for the discovery and clinical development of targeted molecular therapeutics. , 2012, Annual review of pharmacology and toxicology.

[161]  R. Cavalli,et al.  Solid lipospheres of doxorubicin and idarubicin , 1993 .

[162]  Lin Mei,et al.  Nanotheranostics ˗ Application and Further Development of Nanomedicine Strategies for Advanced Theranostics , 2014, Theranostics.

[163]  G. Yener,et al.  Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives , 2007, International journal of nanomedicine.

[164]  D. Mukhopadhyay,et al.  Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. , 2008, Cancer research.

[165]  C. Horak,et al.  Nivolumab plus ipilimumab in advanced melanoma. , 2013, The New England journal of medicine.

[166]  M. Andreeff,et al.  Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. , 2002, Cancer research.

[167]  Xiaohua Huang,et al.  Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. , 2005, Nano letters.

[168]  C. Otley,et al.  The management of melanoma and nonmelanoma skin cancer: a review for the primary care physician. , 2001, Mayo Clinic proceedings.

[169]  D. Davies,et al.  TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population , 2010, British Journal of Cancer.

[170]  P. Hersey,et al.  Treatment of metastatic melanoma using electroporation therapy with bleomycin (electrochemotherapy) , 2005, Melanoma research.

[171]  M Keidar,et al.  Cold plasma selectivity and the possibility of a paradigm shift in cancer therapy , 2011, British Journal of Cancer.

[172]  Hui Zhang,et al.  Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells. , 2007, Nano letters.

[173]  Sikandar G. Khan,et al.  No association between three xeroderma pigmentosum group C and one group G gene polymorphisms and risk of cutaneous melanoma , 2005, European Journal of Human Genetics.

[174]  G. Choi,et al.  Inhibition of c-Kit signaling by diosmetin isolated from Chrysanthemum morifolium , 2013, Archives of pharmacal research.

[175]  S. Nair,et al.  Curcumin loaded chitin nanogels for skin cancer treatment via the transdermal route. , 2012, Nanoscale.

[176]  Dan Peer,et al.  Tumor targeting profiling of hyaluronan-coated lipid based-nanoparticles. , 2014, Nanoscale.

[177]  J. Blenis,et al.  Phosphorylation of p90 Ribosomal S6 Kinase (RSK) Regulates Extracellular Signal-Regulated Kinase Docking and RSK Activity , 2003, Molecular and Cellular Biology.

[178]  Takeshi Mori,et al.  Poly(ethylene glycol)-Modified Gold Nanorods as a Photothermal Nanodevice for Hyperthermia , 2009, Journal of biomaterials science. Polymer edition.

[179]  I. L. Le Poole,et al.  HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo. , 2008, The Journal of investigative dermatology.

[180]  S. Hsu,et al.  Formulation design and evaluation of quantum dot-loaded nanostructured lipid carriers for integrating bioimaging and anticancer therapy. , 2013, Nanomedicine.

[181]  R. Duncan,et al.  Dendrimer-platinate: a novel approach to cancer chemotherapy. , 1999, Anti-cancer drugs.

[182]  Mira Kim,et al.  A spatiotemporal anticancer drug release platform of PEGylated graphene oxide triggered by glutathione in vitro and in vivo , 2012 .

[183]  F. Farzaneh,et al.  Protein transduction: an alternative to genetic intervention? , 2001, Gene Therapy.

[184]  Stanley J. Miller,et al.  Treatment options in melanoma in situ: topical and radiation therapy, excision and Mohs surgery , 2010, International journal of dermatology.

[185]  A. S. Sobolev,et al.  Recombinant modular transporters for cell‐specific nuclear delivery of locally acting drugs enhance photosensitizer activity , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[186]  Yi Sun,et al.  Small RING Finger Proteins RBX1 and RBX2 of SCF E3 Ubiquitin Ligases: The Role in Cancer and as Cancer Targets. , 2010, Genes & cancer.

[187]  Victoria L. Lazareth,et al.  Management of non-melanoma skin cancer. , 2013, Seminars in oncology nursing.

[188]  T. Hieken,et al.  Compliance with Melanoma Treatment Guidelines in a Community Teaching Hospital: Time Trends and Other Variables , 2008, Annals of Surgical Oncology.

[189]  N. Hayward,et al.  Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma , 1996, Nature Genetics.

[190]  S. Amini,et al.  Nonsurgical innovations in the treatment of nonmelanoma skin cancer. , 2010, The Journal of clinical and aesthetic dermatology.

[191]  F. Garbagnati,et al.  HSP-70, C-myc and HLA-DR expression in patients with cutaneous malignant melanoma metastatic in lymph nodes. , 2006, Anticancer research.

[192]  P. Uribe,et al.  Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy. , 2011, Pathology, research and practice.

[193]  M. Ferrarini,et al.  Constitutive expression of the heat shock protein 72 kDa in human melanoma cells. , 1994, Cancer letters.

[194]  Di Chen,et al.  Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[195]  S. Jarrett,et al.  UV Radiation and the Skin , 2013, International journal of molecular sciences.

[196]  Kinam Park,et al.  Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer. , 2012, Colloids and surfaces. B, Biointerfaces.

[197]  Eviatar Nevo,et al.  Genetic variation in nature , 2011, Scholarpedia.

[198]  P. Ascierto,et al.  Update on PEG-interferon α-2b as adjuvant therapy in melanoma. , 2012, Anticancer research.

[199]  Kullervo Hynynen,et al.  Overview of Therapeutic Ultrasound Applications and Safety Considerations , 2012, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[200]  Q. Wei,et al.  Haplotype and genotypes of the VDR gene and cutaneous melanoma risk in non‐Hispanic whites in Texas: A case–control study , 2008, International journal of cancer.

[201]  Alfonso Latorre,et al.  DNA and aptamer stabilized gold nanoparticles for targeted delivery of anticancer therapeutics. , 2014, Nanoscale.

[202]  Juergen F. Kolb,et al.  A new pulsed electric field therapy for melanoma disrupts the tumor's blood supply and causes complete remission without recurrence , 2009, International journal of cancer.

[203]  Prashant K. Jain,et al.  Plasmonic photothermal therapy (PPTT) using gold nanoparticles , 2008, Lasers in Medical Science.

[204]  R. Braga,et al.  Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[205]  Forrest M Kievit,et al.  Cancer Nanotheranostics: Improving Imaging and Therapy by Targeted Delivery Across Biological Barriers , 2011, Advanced materials.

[206]  M. Bryszewska,et al.  Dendrimers: properties and applications. , 2001, Acta biochimica Polonica.

[207]  Yong-Yeon Cho,et al.  A Rising Cancer Prevention Target of RSK2 in Human Skin Cancer , 2013, Front. Oncol..

[208]  Lin Li,et al.  Water‐Soluble Poly(N‐isopropylacrylamide)–Graphene Sheets Synthesized via Click Chemistry for Drug Delivery , 2011 .

[209]  S. Benita,et al.  A new in vitro technique for the evaluation of drug release profile from colloidal carriers - ultrafiltration technique at low pressure , 1993 .

[210]  C. El-Haibi,et al.  Mesenchymal Stem Cells in the Pathogenesis and Therapy of Breast Cancer , 2010, Journal of Mammary Gland Biology and Neoplasia.

[211]  Jennifer L. West,et al.  Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines , 2007, Journal of Neuro-Oncology.

[212]  I. Guzhova,et al.  Hsp70 chaperone-based gel composition as a novel immunotherapeutic anti-tumor tool , 2012, Cell Stress and Chaperones.

[213]  Javed Ali,et al.  Nanostructured lipid carriers system: Recent advances in drug delivery , 2012, Journal of drug targeting.

[214]  K. Finegan,et al.  Molecular and Cellular Pathobiology the Mitogen-activated Protein Kinase Kinase 4 Has a Pro-oncogenic Role in Skin Cancer , 2022 .

[215]  W. Byrne,et al.  Enhancement of electroporation facilitated immunogene therapy via T-reg depletion , 2014, Cancer Gene Therapy.

[216]  B. Nickoloff,et al.  Life and death signaling pathways contributing to skin cancer. , 2002, The journal of investigative dermatology. Symposium proceedings.

[217]  K. Nguyen,et al.  Multifunctional particles for melanoma-targeted drug delivery. , 2012, Acta biomaterialia.

[218]  J. Aitken,et al.  Clinical practice guidelines for the management of melanoma in Australia and New Zealand , 2008 .

[219]  Alan Ashworth,et al.  Translating cancer research into targeted therapeutics , 2010, Nature.

[220]  Richard Heller,et al.  Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[221]  Rochlitz Cf Gene therapy of cancer. , 2001 .

[222]  P. Schiller,et al.  Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors. , 2010, Biomaterials.

[223]  R. Müller,et al.  Lipid Nanoparticles with a Solid Matrix (SLN®, NLC®, LDC®) for Oral Drug Delivery , 2008, Drug development and industrial pharmacy.

[224]  J. Pardeike,et al.  Nanostructured lipid carriers (NLC) in cosmetic dermal products. , 2007, Advanced drug delivery reviews.

[225]  B. Müller,et al.  Lipid emulsions as a novel system to reduce the hemolytic activity of lytic agents: mechanism of the protective effect. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[226]  Galo J. A. A. Soler-Illia,et al.  Hyaluronan degrading silica nanoparticles for skin cancer therapy. , 2013, Nanoscale.

[227]  John H. Zhang,et al.  Cold Atmospheric Plasma: methods of production and application in dentistry and oncology , 2013, Medical gas research.

[228]  Sonke Svenson,et al.  Dendrimers as versatile platform in drug delivery applications. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[229]  P. Black,et al.  Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[230]  Kostas Kostarelos,et al.  Tumor targeting of functionalized quantum dot-liposome hybrids by intravenous administration. , 2009, Molecular pharmaceutics.

[231]  J M Dubernard,et al.  Transrectal high-intensity focused ultrasound: minimally invasive therapy of localized prostate cancer. , 2000, Journal of endourology.

[232]  P. Potter,et al.  Therapeutic targeting of melanoma cells using neural stem cells expressing carboxylesterase, a CPT-11 activating enzyme. , 2010, Current stem cell research & therapy.

[233]  P. Dobbin,et al.  Macromolecular delivery of 5-aminolaevulinic acid for photodynamic therapy using dendrimer conjugates , 2007, Molecular Cancer Therapeutics.

[234]  Tzung-Han Chou,et al.  The molecular effects of aloe-emodin (AE)/liposome-AE on human nonmelanoma skin cancer cells and skin permeation. , 2009, Chemical research in toxicology.

[235]  T. Tüting,et al.  Biolistic DNA vaccination against melanoma. , 2013, Methods in molecular biology.

[236]  J. Mark Elwood,et al.  Melanoma and sun exposure: An overview of published studies , 1997, International journal of cancer.

[237]  M. H. Santana,et al.  Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery , 2011, Journal of drug delivery.

[238]  A. Hauschild,et al.  Optimization of photodynamic therapy with a novel self‐adhesive 5‐aminolaevulinic acid patch: results of two randomized controlled phase III studies , 2009, The British journal of dermatology.

[239]  B. Logan,et al.  The Skin Cancer Index: Clinical Responsiveness and Predictors of Quality of Life , 2007, The Laryngoscope.

[240]  D. A. Russell,et al.  The in vivo efficacy of phthalocyanine-nanoparticle conjugates for the photodynamic therapy of amelanotic melanoma. , 2010, European journal of cancer.

[241]  Yuquan Wei,et al.  A tumor-selective biotherapy with prolonged impact on established metastases based on cytokine gene-engineered MSCs. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[242]  D. Crommelin,et al.  Liposomal and Lipid Formulations of Amphotericin B , 1992, Clinical pharmacokinetics.

[243]  R. Dronca,et al.  Latest advances in chemotherapeutic, targeted, and immune approaches in the treatment of metastatic melanoma. , 2014, Mayo Clinic proceedings.

[244]  M. Aickin,et al.  Importance of the form of topical vitamin E for prevention of photocarcinogenesis. , 1996, Nutrition and cancer.

[245]  Baowei Fei,et al.  Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. , 2008, Journal of the American Chemical Society.

[246]  Arezou A Ghazani,et al.  Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.

[247]  Massoud Motamedi,et al.  Engineering of hetero-functional gold nanorods for the in vivo molecular targeting of breast cancer cells. , 2009, Nano letters.

[248]  J. Reichrath Molecular Mechanisms of Basal Cell and Squamous Cell Carcinomas , 2006 .

[249]  M. Gore,et al.  Revised UK guidelines for the management of cutaneous melanoma 2010. , 2010, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[250]  J. Kennedy High-intensity focused ultrasound in the treatment of solid tumours , 2005, Nature Reviews Cancer.

[251]  M. Wirth,et al.  Delivery of carboplatin by carbon-based nanocontainers mediates increased cancer cell death , 2010, Nanotechnology.

[252]  Y. Tabata,et al.  Mesenchymal stem cells: a promising targeted-delivery vehicle in cancer gene therapy. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[253]  N. Zhang,et al.  Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. , 2011, Colloids and surfaces. B, Biointerfaces.

[254]  C. Hauge,et al.  RSK and MSK in MAP kinase signalling , 2006, Journal of Cell Science.

[255]  W. D. de Jong,et al.  Drug delivery and nanoparticles: Applications and hazards , 2008, International journal of nanomedicine.

[256]  S. Rosso,et al.  Occupation and skin cancer: the results of the HELIOS-I multicenter case-control study , 2007, BMC public health.

[257]  H. Merk,et al.  Improving Topical Non-Melanoma Skin Cancer Treatment: In vitro Efficacy of a Novel Guanosine-Analog Phosphonate , 2014, Skin Pharmacology and Physiology.

[258]  C. Montero-Menei,et al.  The potential of combinations of drug-loaded nanoparticle systems and adult stem cells for glioma therapy. , 2011, Biomaterials.

[259]  P. Wolf,et al.  Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study , 2001, The Lancet.

[260]  D. Maria,et al.  Association of daunorubicin to a lipid nanoemulsion that binds to low‐density lipoprotein receptors enhances the antitumour action and decreases the toxicity of the drug in melanoma‐bearing mice , 2014, The Journal of pharmacy and pharmacology.

[261]  M. Pomplun,et al.  A Randomized, Double-Blind, Placebo-Controlled Phase 3 Skin Cancer Prevention Study of α-Difluoromethylornithine in Subjects with Previous History of Skin Cancer , 2010, Cancer Prevention Research.

[262]  P. Clarke Nonmelanoma skin cancers - treatment options. , 2012, Australian family physician.

[263]  K. Flaherty Targeting metastatic melanoma. , 2012, Annual review of medicine.

[264]  G. Rossi,et al.  Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy. , 2010, Cancer research.

[265]  Leaf Huang,et al.  Targeted nanoparticles deliver siRNA to melanoma. , 2010, The Journal of investigative dermatology.

[266]  G. Robertson,et al.  Combining Nanoliposomal Ceramide with Sorafenib Synergistically Inhibits Melanoma and Breast Cancer Cell Survival to Decrease Tumor Development , 2008, Clinical Cancer Research.

[267]  M. Edidin,et al.  Nanoscale artificial antigen presenting cells for T cell immunotherapy. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[268]  F. T. ten Cate,et al.  Radionuclide tumour therapy with ultrasound contrast microbubbles. , 2004, Ultrasonics.

[269]  Karsten Mäder,et al.  Solid lipid nanoparticles , 2012 .

[270]  Brett M Coldiron,et al.  No end in sight: the skin cancer epidemic continues. , 2011, Seminars in cutaneous medicine and surgery.

[271]  Tej B. Shrestha,et al.  Stem cell-based photodynamic therapy , 2012, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[272]  H. Dai,et al.  Carbon nanotubes as intracellular protein transporters: generality and biological functionality. , 2005, Journal of the American Chemical Society.

[273]  Ivan H. El-Sayed,et al.  Nanotechnology in Head and Neck Cancer: The Race Is On , 2010, Current oncology reports.

[274]  A. Tedesco,et al.  Photophysical studies and in vitro skin permeation/retention of Foscan/nanoemulsion (NE) applicable to photodynamic therapy skin cancer treatment. , 2008, Journal of nanoscience and nanotechnology.

[275]  J. Cadeddu,et al.  Efficacy of laser-activated gold nanoshells in ablating prostate cancer cells in vitro. , 2007, Journal of endourology.

[276]  Ya-ju Chang,et al.  Phospholipid-functionalized mesoporous silica nanocarriers for selective photodynamic therapy of cancer. , 2013, Biomaterials.

[277]  D. Wallace Mitochondria and cancer , 2012, Nature Reviews Cancer.

[278]  D. Alberts,et al.  Phase 1 Study of Topical Perillyl Alcohol Cream for Chemoprevention of Skin Cancer , 2008, Nutrition and cancer.

[279]  C. Der,et al.  Inhibition of Ras for cancer treatment: the search continues. , 2011, Future medicinal chemistry.

[280]  Tzeng-Ji Chen,et al.  Amiodarone and the risk of cancer , 2013, Cancer.

[281]  Jie Huang,et al.  Polyethylenimine-functionalized graphene oxide as an efficient gene delivery vector , 2011 .

[282]  H. Kılıç,et al.  Femtosecond laser induced photodynamic therapy on 5-ALA treated SKMEL-30 cells: an efficient theranostic strategy to combat melanoma. , 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[283]  J. L. van Delft,et al.  The effects of ultrasonically induced hyperthermia on experimental tumors in the rabbit eye. , 1989, Investigative ophthalmology & visual science.

[284]  Jia-bi Zhu,et al.  Body Distribution of Camptothecin Solid Lipid Nanoparticles After Oral Administration , 1999, Pharmaceutical Research.

[285]  Y. Huang,et al.  A meta-analysis of DNA repair gene XPC polymorphisms and cancer risk , 2008, Journal of Human Genetics.

[286]  Z. Lou,et al.  The cytotoxicity of OPA-modified CdSe/ZnS core/shell quantum dots and its modulation by silibinin in human skin cells. , 2011, Journal of Biomedical Nanotechnology.

[287]  P. Bartels,et al.  A Phase 2a Study of Topical Perillyl Alcohol Cream for Chemoprevention of Skin Cancer , 2010, Cancer Prevention Research.

[288]  Tarek R. Fadel,et al.  A carbon nanotube-polymer composite for T-cell therapy. , 2014, Nature nanotechnology.

[289]  Leon Hirsch,et al.  Nanoshell-Enabled Photonics-Based Imaging and Therapy of Cancer , 2004, Technology in cancer research & treatment.

[290]  J. Wolchok,et al.  At the Bedside: CTLA‐4‐ and PD‐1‐blocking antibodies in cancer immunotherapy , 2013, Journal of leukocyte biology.

[291]  J. Wenzel,et al.  Toll-like receptor-agonists in the treatment of skin cancer: history, current developments and future prospects. , 2008, Handbook of experimental pharmacology.

[292]  Taeghwan Hyeon,et al.  Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery. , 2010, Journal of the American Chemical Society.

[293]  V. de Giorgi,et al.  Cutaneous toxicities of BRAF inhibitors: clinical and pathological challenges and call to action. , 2013, Critical reviews in oncology/hematology.

[294]  A. Baccarelli,et al.  XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk , 2004, British Journal of Cancer.

[295]  Probal Banerjee,et al.  In-situ immobilization of quantum dots in polysaccharide-based nanogels for integration of optical pH-sensing, tumor cell imaging, and drug delivery. , 2010, Biomaterials.

[296]  Elaine Fuchs,et al.  Scratching the surface of skin development , 2007, Nature.

[297]  A. Aplin,et al.  Paying "particle" attention to novel melanoma treatment strategies. , 2010, The Journal of investigative dermatology.

[298]  G. Singh,et al.  Mitochondria and Cancer: Past, Present, and Future , 2013, BioMed research international.

[299]  G. Peters Tumor suppression for ARFicionados: the relative contributions of p16INK4a and p14ARF in melanoma. , 2008, Journal of the National Cancer Institute.

[300]  Zhuang Liu,et al.  Graphene based gene transfection. , 2011, Nanoscale.

[301]  D. Schadendorf,et al.  Clinical Phase II Study of Pegylated Liposomal Doxorubicin as Second-Line Treatment in Disseminated Melanoma , 2004, Oncology Research and Treatment.

[302]  Richard Heller,et al.  Electroporation gene therapy preclinical and clinical trials for melanoma. , 2010, Current gene therapy.

[303]  H. Pehamberger Perspectives of pegylated interferon use in dermatological oncology. , 2002, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[304]  L. Naldi,et al.  The epidemiology of skin cancer , 2002, The British journal of dermatology.

[305]  R. Patlolla,et al.  Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery , 2010, Molecular membrane biology.

[306]  A. Daud,et al.  Plasmid IL-12 electroporation in melanoma , 2012, Human vaccines & immunotherapeutics.

[307]  M. Üner Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems. , 2006, Die Pharmazie.

[308]  T. Xia,et al.  Toxic Potential of Materials at the Nanolevel , 2006, Science.

[309]  A. S. Sobolev,et al.  Targeting cancer cells by novel engineered modular transporters. , 2006, Cancer research.

[310]  J. Leoni,et al.  Cyclooxygenase-2 Overexpression in Non-Melanoma Skin Cancer: Molecular Pathways Involved as Targets for Prevention and Treatment , 2011 .

[311]  C. Chiang,et al.  First demonstration of gold nanorods-mediated photodynamic therapeutic destruction of tumors via near infra-red light activation. , 2014, Small.

[312]  C. Garbe,et al.  New landscape in the treatment of melanoma: a 2012 update , 2013, Oncologie.

[313]  P. Selvaraj,et al.  A novel microparticulate vaccine for melanoma cancer using transdermal delivery , 2011, Journal of microencapsulation.

[314]  Gregory Fridman,et al.  Floating Electrode Dielectric Barrier Discharge Plasma in Air Promoting Apoptotic Behavior in Melanoma Skin Cancer Cell Lines , 2007 .

[315]  Zhuoxuan Lu,et al.  Enhanced chemotherapy efficacy by sequential delivery of siRNA and anticancer drugs using PEI-grafted graphene oxide. , 2011, Small.

[316]  J. Pardeike,et al.  Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. , 2009, International journal of pharmaceutics.

[317]  F. Ghiringhelli,et al.  Stratégies vaccinales contre le mélanome , 2006 .

[318]  A. Elaissari,et al.  Nanotechnology olymer-based nanocapsules for drug delivery , 2009 .

[319]  D. Schadendorf Gene-based therapy of malignant melanoma. , 2002, Seminars in oncology.

[320]  G. Botti,et al.  Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis , 2013, BMC Cancer.

[321]  Tingting Zheng,et al.  Green and facile synthesis of highly biocompatible graphene nanosheets and its application for cellular imaging and drug delivery , 2011 .

[322]  P. Boyle,et al.  Cancer of the skin: a forgotten problem in Europe. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[323]  Do Hee Keum,et al.  Nanographene oxide-hyaluronic acid conjugate for photothermal ablation therapy of skin cancer. , 2014, ACS nano.

[324]  D. Hirst,et al.  Gold nanoparticles as novel agents for cancer therapy. , 2012, The British journal of radiology.

[325]  A. Kabanov,et al.  Nanogels as pharmaceutical carriers: finite networks of infinite capabilities. , 2009, Angewandte Chemie.

[326]  S. Saraf,et al.  Biocompatible nanoparticles for sustained topical delivery of anticancer phytoconstituent quercetin. , 2013, Pakistan journal of biological sciences : PJBS.

[327]  A. Hauschild,et al.  Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[328]  Zhuang Liu,et al.  PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. , 2008, Journal of the American Chemical Society.

[329]  M. Nango,et al.  Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA delivery. , 2014, Biochemical and biophysical research communications.

[330]  G. Robertson,et al.  Use of liposomes as drug delivery vehicles for treatment of melanoma , 2009, Pigment cell & melanoma research.

[331]  F. Iza,et al.  Air plasma coupled with antibody-conjugated nanoparticles: a new weapon against cancer , 2009 .

[332]  A. Offidani,et al.  Electrochemotherapy: an effective local treatment of cutaneous and subcutaneous melanoma metastases , 2014, Dermatologic therapy.

[333]  Friedrich P Thinnes Nonmelanoma skin cancer is associated with reduced Alzheimer disease risk , 2013, Neurology.

[334]  U. Liebert,et al.  Antitumoral and antimetastatic effects of continuous particle-mediated cytokine gene therapy. , 2003, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[335]  R. Stafford,et al.  Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[336]  T. Andresen,et al.  Hyaluronic acid immobilized polyacrylamide nanoparticle sensors for CD44 receptor targeting and pH measurement in cells. , 2012, Bioconjugate chemistry.

[337]  Aditya K. Gupta,et al.  Onychomycosis: review of recurrence rates, poor prognostic factors, and strategies to prevent disease recurrence. , 2004, Cutis.

[338]  J. Bordeaux,et al.  Non-melanoma skin cancers: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies. , 2013, Clinics in dermatology.

[339]  Y. Tomer,et al.  Opportunistic autoimmune disorders , 2010, Annals of the New York Academy of Sciences.

[340]  T. Desser,et al.  New technologies in clinical ultrasound. , 2013, Seminars in roentgenology.

[341]  Indrajit Roy,et al.  Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. , 2003, Journal of the American Chemical Society.

[342]  Hugh M Gloster,et al.  Skin cancer in skin of color. , 2006, Journal of the American Academy of Dermatology.

[343]  D Miklavcic,et al.  Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis. , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[344]  D. Rigel,et al.  Epidemiology of melanoma. , 2010, Seminars in cutaneous medicine and surgery.

[345]  Chengxiang Li,et al.  In Vivo Evidences of Nanosecond Pulsed Electric Fields for Melanoma Malignancy Treatment on Tumor-Bearing BALB/c Nude Mice , 2014, Technology in cancer research & treatment.

[346]  R. Rao,et al.  Sonophoresis: recent advancements and future trends , 2009, The Journal of pharmacy and pharmacology.

[347]  A. Olszanski Current and Future Roles of Targeted Therapy and Immunotherapy in Advanced Melanoma , 2014, Journal of managed care & specialty pharmacy.

[348]  Ponti Giovanni,et al.  Molecular Targeted Approaches for Advanced BRAF V600, N-RAS, c-KIT, and GNAQ Melanomas , 2014, Disease Markers.

[349]  Chitta Ranjan Patra,et al.  Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. , 2010, Advanced drug delivery reviews.

[350]  M. López-Quintela,et al.  Penetration of metallic nanoparticles in human full-thickness skin. , 2007, The Journal of investigative dermatology.

[351]  Alessandro Testori,et al.  Utility of electrochemotherapy in melanoma treatment , 2012, Current opinion in oncology.

[352]  Jinhua Xu,et al.  Icariside II induces apoptosis via inhibition of the EGFR pathways in A431 human epidermoid carcinoma cells. , 2013, Molecular medicine reports.

[353]  Tomoyuki Miyagawa,et al.  Inhibition of Hsp90 and 70 sensitizes melanoma cells to hyperthermia using ferromagnetic particles with a low Curie temperature , 2014, International Journal of Clinical Oncology.

[354]  Stanley J. Miller,et al.  Mohs Surgery for the Treatment of Melanoma in Situ: A Review , 2007, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[355]  K. Plichta,et al.  Radiotherapy for cutaneous malignancies of the head and neck , 2013 .

[356]  Qiang Wu,et al.  The therapeutic efficacy of CdTe and CdSe quantum dots for photothermal cancer therapy. , 2012, Biomaterials.

[357]  K. Flaherty,et al.  Targeting the RAS pathway in melanoma. , 2012, Trends in molecular medicine.

[358]  Kate S. Carroll,et al.  Downregulation of tumor growth and invasion by redox-active nanoparticles. , 2013, Antioxidants & redox signaling.

[359]  G. Colditz,et al.  Genetic Variation in XPD, Sun Exposure, and Risk of Skin Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[360]  P. Kabouridis Biological applications of protein transduction technology. , 2003, Trends in biotechnology.

[361]  Kevin B. Kim,et al.  Dabrafenib for treatment of BRAF-mutant melanoma , 2013, Pharmacogenomics and personalized medicine.

[362]  M. Prato,et al.  Antitumor activity and prolonged survival by carbon-nanotube-mediated therapeutic siRNA silencing in a human lung xenograft model. , 2009, Small.

[363]  Ralph Weissleder,et al.  Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy , 2009, Proceedings of the National Academy of Sciences.

[364]  Rainer H. Müller,et al.  20 Years of Lipid Nanoparticles (SLN & NLC): Present State of Development & Industrial Applications , 2011 .

[365]  N. Comfere,et al.  Molecular targeted therapies in metastatic melanoma , 2013, Pharmacogenomics and personalized medicine.

[366]  T. Sasada,et al.  Combinational delivery of lipid-enveloped polymeric nanoparticles carrying different peptides for anti-tumor immunotherapy. , 2014, Nanomedicine.

[367]  F. Szoka,et al.  Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor. , 2008, Molecular pharmaceutics.

[368]  A. Chang,et al.  Advanced Basal Cell Carcinoma: Epidemiology and Therapeutic Innovations , 2014, Current Dermatology Reports.

[369]  Mark Borden,et al.  Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. , 2007, Annual review of biomedical engineering.

[370]  C. Sung,et al.  Nanocomposite liposomes containing quantum dots and anticancer drugs for bioimaging and therapeutic delivery: a comparison of cationic, PEGylated and deformable liposomes , 2013, Nanotechnology.

[371]  D. Schadendorf,et al.  Gene-based immunotherapy of skin cancers. , 2002, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[372]  Lin Li,et al.  Functionalized carbon nanomaterials as nanocarriers for loading and delivery of a poorly water-soluble anticancer drug: a comparative study. , 2011, Chemical communications.

[373]  Mansoor Amiji,et al.  Long-Circulating Poly(Ethylene Glycol)-Modified Gelatin Nanoparticles for Intracellular Delivery , 2002, Pharmaceutical Research.

[374]  N. Kanikkannan Iontophoresis-Based Transdermal Delivery Systems , 2012, BioDrugs.

[375]  J. Hainfeld,et al.  The use of gold nanoparticles to enhance radiotherapy in mice. , 2004, Physics in medicine and biology.

[376]  R. Tang,et al.  Epirubicin-loaded superparamagnetic iron-oxide nanoparticles for transdermal delivery: cancer therapy by circumventing the skin barrier. , 2015, Small.

[377]  J. Naeyaert,et al.  Understanding the trends in melanoma incidence and mortality: where do we stand? , 2000, European journal of dermatology : EJD.

[378]  M. Małecki,et al.  siRNA preparations in gene therapy of melanoma. , 2013, Medycyna wieku rozwojowego.

[379]  P. Fisher,et al.  A multifunctional chimeric chaperone serves as a novel immune modulator inducing therapeutic antitumor immunity. , 2013, Cancer research.

[380]  O. Shakhova Neural crest stem cells in melanoma development , 2014, Current opinion in oncology.

[381]  Wei Lu,et al.  Targeted Photothermal Ablation of Murine Melanomas with Melanocyte-Stimulating Hormone Analog–Conjugated Hollow Gold Nanospheres , 2009, Clinical Cancer Research.

[382]  Yuan Ping,et al.  Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery. , 2011, Small.

[383]  Mark R Prausnitz,et al.  Bioeffects caused by changes in acoustic cavitation bubble density and cell concentration: a unified explanation based on cell-to-bubble ratio and blast radius. , 2003, Ultrasound in medicine & biology.

[384]  A. Hauschild,et al.  Surgery and radiotherapy in the treatment of cutaneous melanoma , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[385]  T. H. Nguyen,et al.  Nonmelanoma skin cancer , 2002, Current treatment options in oncology.

[386]  M. Fu,et al.  Induction of protective and therapeutic antitumour immunity using a novel tumour‐associated antigen‐specific DNA vaccine , 2006, Immunology and cell biology.

[387]  H. Geng,et al.  HSP70 vaccine in combination with gene therapy with plasmid DNA encoding sPD‐1 overcomes immune resistance and suppresses the progression of pulmonary metastatic melanoma , 2006, International journal of cancer.

[388]  A. Lu,et al.  Magnetic nanoparticles: synthesis, protection, functionalization, and application. , 2007, Angewandte Chemie.

[389]  M. Fu,et al.  [Antitumor effect of gene gun-mediated DNA vaccine pWRG-neu immunization in C57BL/6 mice]. , 2003, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[390]  A. Stratigos,et al.  Emerging trends in the epidemiology of melanoma , 2014, The British journal of dermatology.

[391]  E. Unger,et al.  Therapeutic applications of lipid-coated microbubbles. , 2004, Advanced drug delivery reviews.

[392]  Murad Alam,et al.  Epidermal Growth Factor Receptor Inhibitors in the Treatment of Nonmelanoma Skin Cancers , 2011, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[393]  H. Gollnick,et al.  Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod. , 2004, The Journal of investigative dermatology.

[394]  K. Char,et al.  Delivery of a therapeutic protein for bone regeneration from a substrate coated with graphene oxide. , 2013, Small.

[395]  H. Mitsui,et al.  Novel immunotherapeutic approaches to skin cancer treatments using protein transduction technology. , 2011, Journal of dermatological science.

[396]  Josep Malvehy,et al.  Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016. , 2012, European journal of cancer.

[397]  C. Puglia,et al.  Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals , 2012, Expert opinion on drug delivery.

[398]  J. S. Mulliken,et al.  The effect of sunscreen on melanoma risk. , 2002, Dermatologic clinics.

[399]  A. Melcher,et al.  Killing of Normal Melanocytes, Combined with Heat Shock Protein 70 and CD40L Expression, Cures Large Established Melanomas , 2006, The Journal of Immunology.

[400]  E. E. Carpenter,et al.  Chemically prepared magnetic nanoparticles , 2004 .

[401]  J. Uitto,et al.  The gene gun: current applications in cutaneous gene therapy , 2000, International journal of dermatology.

[402]  Yi Sun,et al.  SCF E3 ubiquitin ligases as anticancer targets. , 2011, Current cancer drug targets.

[403]  S. Bossmann,et al.  Attenuation of mouse melanoma by A/C magnetic field after delivery of bi-magnetic nanoparticles by neural progenitor cells. , 2010, ACS nano.

[404]  A. Berger,et al.  RAF inhibition overcomes resistance to TRAIL-induced apoptosis in melanoma cells. , 2014, The Journal of investigative dermatology.

[405]  F. Gruijl Skin cancer and solar UV radiation , 1999 .

[406]  M. Andreeff,et al.  Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. , 2005, Cancer research.

[407]  M. Mihm,et al.  CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS , 2008, Nature Clinical Practice Oncology.

[408]  Peter McLoughlin,et al.  Microneedle mediated delivery of nanoparticles into human skin. , 2009, International journal of pharmaceutics.

[409]  M. Woodle,et al.  Sterically stabilized liposome therapeutics , 1995 .

[410]  L. Löfgren,et al.  Electroporation Therapy of Skin Cancer in the Head and Neck Area , 2010, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[411]  H. Noguchi,et al.  Protein transduction technology: a novel therapeutic perspective. , 2006, Acta medica Okayama.

[412]  Yong-Yeon Cho,et al.  RSK2 as a key regulator in human skin cancer. , 2012, Carcinogenesis.

[413]  Il-Kwon Oh,et al.  Graphene oxide-polyethylenimine nanoconstruct as a gene delivery vector and bioimaging tool. , 2011, Bioconjugate chemistry.

[414]  Dar-Bin Shieh,et al.  Nanoshell Magnetic Resonance Imaging Contrast Agents , 2007, 2007 Digest of papers Microprocesses and Nanotechnology.

[415]  V. del Marmol,et al.  Melanoma incidence and mortality in Europe: new estimates, persistent disparities , 2012, The British journal of dermatology.

[416]  Yun Zhou,et al.  Pulsed ultrasound enhances nanoparticle penetration into breast cancer spheroids. , 2010, Molecular pharmaceutics.

[417]  Claus Garbe,et al.  Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight. , 2008, Advances in experimental medicine and biology.

[418]  J. Kładny,et al.  Common variants of DNA repair genes and malignant melanoma. , 2008, European journal of cancer.

[419]  R. Müller,et al.  Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. , 2002, Advanced drug delivery reviews.

[420]  Hasan Mukhtar,et al.  Impact of nanotechnology in cancer: emphasis on nanochemoprevention , 2012, International journal of nanomedicine.

[421]  J. Wolchok,et al.  Annals of the New York Academy of Sciences Development of Ipilimumab: a Novel Immunotherapeutic Approach for the Treatment of Advanced Melanoma , 2022 .

[422]  K. Ishii,et al.  Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.

[423]  Martin A Weinstock,et al.  Cutaneous melanoma: public health approach to early detection , 2006, Dermatologic therapy.

[424]  R. Millikan,et al.  Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study. , 2006, Carcinogenesis.

[425]  F. Noonan,et al.  The effects on human health from stratospheric ozone depletion and its interactions with climate change , 2007, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[426]  Yoshiyuki Hattori,et al.  Ultra-deformable liposomes containing bleomycin: in vitro stability and toxicity on human cutaneous keratinocyte cell lines. , 2005, International journal of pharmaceutics.

[427]  J. Brandner,et al.  The skin: an indispensable barrier , 2008, Experimental dermatology.

[428]  A. Testori,et al.  Treatment of metastatic melanoma with electrochemotherapy , 2014, Journal of surgical oncology.

[429]  A. S. Sobolev,et al.  Modular nanotransporters: a multipurpose in vivo working platform for targeted drug delivery , 2012, International journal of nanomedicine.

[430]  C. Lawrence,et al.  Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma , 2002, British journal of plastic surgery.

[431]  A. Sober,et al.  Melanoma treatment update. , 2005, Dermatologic clinics.

[432]  A. Nomizo,et al.  Development of cationic solid lipid nanoparticles with factorial design-based studies for topical administration of doxorubicin. , 2012, Journal of biomedical nanotechnology.

[433]  Soumen Das,et al.  Multicolored redox active upconverter cerium oxide nanoparticle for bio-imaging and therapeutics. , 2010, Chemical communications.